Comparative Efficacy of Anastrozole, Letrozole, and Fulvestrant as Endocrine Partners Combined with CDK4/6 Inhibitors in Patients with HR+/HER2– Metastatic Breast Cancer: A Real-World Evidence from the Stavropol Regional Clinical Oncology Center. Вопр. онкол. [Internet]. 2025 Dec. 30 [cited 2026 Oct. 14];71(6):OF-2376. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/6-25-Comparative-Efficacy